Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer
INDOCYANINE GREEN for SELECTIVE SENTINELLA AXILLARY LYMPH NODE BIOPSY in PATIENTS with BREAST CANCER
Omphis Foundation
15,000 participants
Jan 1, 2024
OBSERVATIONAL
Conditions
Summary
The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.
Eligibility
Inclusion Criteria2
- Patients \>18 years of age with breast cancer who are candidates for sentinel lymph node detection will be included.
- N0 patients or patients who have undergone target axillary detection with good response
Exclusion Criteria1
- Lymphadenectomy
Interventions
The day of the surgery 1 ml of green indocyanine colorant will be applicated periareolar. After 5 minutes the lymph node will be detected and extracted
Application of a periareolar injectionof TEchnetium 99 in order to detect the axillary lymph node
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06378944